GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Functional Technologies Corp (TSXV:FEB.H) » Definitions » Cash, Cash Equivalents, Marketable Securities

Functional Technologies (TSXV:FEB.H) Cash, Cash Equivalents, Marketable Securities : C$0.42 Mil (As of Aug. 2012)


View and export this data going back to . Start your Free Trial

What is Functional Technologies Cash, Cash Equivalents, Marketable Securities?

Functional Technologies's quarterly cash, cash equivalents, marketable securities increased from Aug. 2010 (C$1.05 Mil) to Aug. 2011 (C$4.34 Mil) but then stayed the same from Aug. 2011 (C$4.34 Mil) to Aug. 2012 (C$0.42 Mil).

Functional Technologies's annual cash, cash equivalents, marketable securities increased from Aug. 2010 (C$1.05 Mil) to Aug. 2011 (C$4.34 Mil) but then declined from Aug. 2011 (C$4.34 Mil) to Aug. 2012 (C$0.42 Mil).


Functional Technologies Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Functional Technologies's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Functional Technologies Cash, Cash Equivalents, Marketable Securities Chart

Functional Technologies Annual Data
Trend Aug03 Aug04 Aug05 Aug06 Aug07 Aug08 Aug09 Aug10 Aug11 Aug12
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.26 2.05 1.05 4.34 0.42

Functional Technologies Semi-Annual Data
Aug01 Aug02 Aug03 Aug04 Aug05 Aug06 Aug07 Aug08 Aug09 Aug10 Aug11 Aug12
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.26 2.05 1.05 4.34 0.42

Functional Technologies Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Functional Technologies  (TSXV:FEB.H) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Functional Technologies Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Functional Technologies's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Functional Technologies (TSXV:FEB.H) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Functional Technologies Corp is incorporated under the corporate laws of British Columbia, Canada on October 18, 1999. The Company is a functional foods and biological health products company that is developing and commercializing advanced yeast products and other novel biological products for the food and health care industry. The company develops and commercializes proprietary, advanced yeast-based solutions to significant challenges in the food, beverage and healthcare industries, for which viable solutions are lacking. The Company's platform technologies improve the performance of innate yeast functions to primarily prevent the formation of naturally occurring toxins and contaminants that either affect final product quality or are classified by various global agencies as dangerous substances (e.g. carcinogens, neurotoxicants or reproductive toxicants). The Company operates in three geographic regions: Canada, Europe and the United States.

Functional Technologies (TSXV:FEB.H) Headlines

No Headlines